Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

43.70
Delayed Data
As of 4:01pm ET
 -0.21 / -0.48%
Today’s Change
37.20
Today|||52-Week Range
45.58
+13.48%
Year-to-Date
Novartis' Erelzi, Biosimilar of Enbrel Approved In Europe
10:01am / Zacks.com - Paid Partner Content
Glaxo's (GSK) Shingles Candidate Phase III Data Positive
Jun 22 / Zacks.com - Paid Partner Content
Top Analyst Reports for Alphabet, Berkshire Hathaway & Nike
Jun 27 / Zacks.com - Paid Partner Content
Novartis Announces Positive Results for Cardiovascular Drug
Jun 22 / Zacks.com - Paid Partner Content
Vaccine Small-Cap Just Took a Big Step Forward
Jun 26 / GuruFocus News - Paid Partner Content
VBI Vaccines Just Took a Major Step Forward in Its HBV Program
Jun 21 / GuruFocus News - Paid Partner Content
Novartis Cardiovascular Drug Positive, NSCLC Drug Approved
Jun 26 / Zacks.com - Paid Partner Content
Novartis (NVS) Biosimilar of MabThera Approved in the EU
Jun 19 / Zacks.com - Paid Partner Content
Hikma Shakes Up U.S. Operations After FDA Disappointment; CEO Said Darwazah to Lead G...
Jun 26 / TheStreet.com - Paid Partner Content
GlaxoSmithKline's Benlysta Positive in Continuation Trial
Jun 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close43.91
Today’s open43.96
Day’s range43.60 - 44.02
Volume2,074,831
Average volume (3 months)2,966,197
Market cap$108.0B
Dividend yield4.55%
Data as of 4:01pm ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+12.57%
Earnings growth (next 5 years)+5.55%
Revenue growth (last year)+2.85%
P/E ratio64.1
Price/Sales2.52
Price/Book76.94

Competitors

 Today’s
change
Today’s
% change
CELGCelgene+3.38+2.58%
ABBVAbbVie+0.53+0.73%
BMYBristol-Myers Squibb-0.03-0.05%
LLYEli Lilly and Co+0.06+0.07%
Data as of 4:14pm ET, 06/28/2017

Financials

Next reporting dateJuly 26, 2017
EPS forecast (this quarter)$0.68
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts